Coagulation inhibitors in alcoholic liver cirrhosis. 1998

J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
Dpto. de Medicina Interna, Hospital Universitario de Canarias, La Laguna, Tenerife, Canary Islands, Spain.

In the present study we have analyzed the relationship between coagulation inhibitors (antithrombin III, protein C and S, thrombomodulin), liver function impairment, and plasma activity of the endothelium-derived proteins plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in 27 alcoholic cirrhotic patients and 25 controls. Cirrhotics showed decreased values of all the mentioned parameters except for thrombomodulin, PAI-1, and t-PA. Thrombomodulin and t-PA levels were higher in cirrhotics. No relationship was observed between thrombomodulin and t-PA or PAI-1. Protein C and antithrombin III levels were significantly lower in Child's C patients, whereas no correlation was found between t-PA and thrombomodulin and hepatic function derangement. PAI-1 activity was normal in our patients.

UI MeSH Term Description Entries
D008104 Liver Cirrhosis, Alcoholic FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING. Alcoholic Cirrhosis,Hepatic Cirrhosis, Alcoholic,Alcoholic Hepatic Cirrhosis,Alcoholic Liver Cirrhosis
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
January 1995, Ryoikibetsu shokogun shirizu,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
January 1994, Nihon rinsho. Japanese journal of clinical medicine,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
February 1988, Klinicheskaia meditsina,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
April 1985, Acta medica Okayama,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
November 1976, Nihon rinsho. Japanese journal of clinical medicine,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
January 1994, Nihon rinsho. Japanese journal of clinical medicine,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
December 1984, Fel'dsher i akusherka,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
February 1956, Journal de medecine de Bordeaux et du Sud-Ouest,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
February 1954, Journal de medecine de Lyon,
J M Raya-Sánchez, and E González-Reimers, and J M Rodríguez-Martín, and F Santolaria-Fernández, and M Molina-Pérez, and F Rodríguez-Moreno, and A Martínez-Riera
May 1993, La Revue du praticien,
Copied contents to your clipboard!